As of July 18, 2026, Blue Lotus (Nymphaea caerulea) is legal to sell at retail in New Hampshire. Not scheduled; criteria-based list tracks federal CSA, which omits it. Controlling source: N.H. Rev. Stat. Ann. Sec. 318-B:1-b (Schedule Tests).
Verified July 18, 2026 · confidence: confirmedNew Hampshire schedules by criteria-based rulemaking delegated to the commissioner (N.H. Rev. Stat. Ann. Sec. 318-B:1-b), with the enumerated Schedule I maintained by administrative rule that tracks the federal CSA list. Neither the NH rules nor federal 21 CFR 1308.11 name Nymphaea caerulea, nuciferine, or apomorphine. No human-consumption restriction. Apomorphine is an FDA legend drug, not a CSA entry. Basis is INTERPRETIVE because NH lacks a single quotable statutory closed list; the conclusion rests on the substance's absence from both NH's federally-aligned rules and the federal CSA they adopt.
The commissioner shall place a substance in schedule I if he finds that the substance: (a) Has high potential for abuse; and (b) Has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision. [NH Schedule I tracks the federal CSA list; neither names Nymphaea, nuciferine, or apomorphine]
Among New Hampshire's 3 neighbors, Maine, Massachusetts and Vermont are legal, the same posture as New Hampshire.
Open the interactive map · Every compound in New Hampshire
Not federally scheduled. Unscheduled federally; FDA has not approved it for human consumption Federal detail
3 instruments on file for this compound's framework in New Hampshire; 1 of 1 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
619a7ad66c8cea56318-B:1 Definitions. -- VI-a. (a) "Controlled drug analog" means a substance, however constituted, the chemical structure of which is derivative of, or substantially similar to that of a controlled drug and: (1) Which has been shown in laboratory studies to bind with and activate the same central nervous receptors that are responsible for the psychoactive effects of a certain controlled drug or controlled drug class; or (2) With respect to a particular person, which such person represents or intends to have similar psychoactive effects on the central nervous system as a controlled drug. (b) "Controlled drug analog" shall not include: (1) A controlled drug; (2) Any substance for which there is an approved new drug application; (3) With respect to a particular person, any substance, if an exemption is in effect for investigational use for that person under 21 U.S.C. section 355, to the extent conduct with respect to the substance is pursuant to such an exemption; or (4) Any compound, mixture, or preparation that contains any controlled drug or controlled drug analog that is not for administration to a human being or animal, and that is packaged in such a form or concentration, or with adulterants or denaturants so that, as packaged, it does not present any significant potential for abuse. XXXI-a. "Substantially similar in chemical structure" means that the substance in question shares a common core structure with a controlled drug, meaning that the "backbone" of the molecule is the same, and has no more than 2 points of divergence (additions, deletions, or substitutions) from the controlled drug, which may consist of a single atom or a functional group or some combination thereof. Functional groups are further defined as alkyl, alkenyl, alkynyl, ring structures (either homocyclic or heterocyclic, with or without additional attached functional groups), organic halides, alkoxy, alcohol, ether, amine, aldehyde, ketone, carboxylic acid, ester, amide, nitrile, nitro, sulfide, thiene, thioester, or thiol.
3fbeffe6c9c96de9**RSA 318-B:1, VI-a(a) (controlled drug analog)** — "'Controlled drug analog' means a substance, however constituted, the chemical structure of which is derivative of, or substantially similar to that of a controlled drug and: (1) Which has been shown in laboratory studies to bind with and activate the same central nervous receptors that are responsible for the psychoactive effects of a certain controlled drug or controlled drug class; or (2) With respect to a particular person, which such person represents or intends to have similar psychoactive effects on the central nervous system as a controlled drug."
— RSA 318-B:1, VI-a(a), https://law.justia.com/codes/new-hampshire/title-xxx/chapter-318-b/section-318-b-1/ (MIRROR: Justia, 2025).
**RSA 318-B:1, XXXI-a ("substantially similar in chemical structure")** — "'Substantially similar in chemical structure' means that the substance in question shares a common core structure with a controlled drug, meaning that the 'backbone' of the molecule is the same, and has no more than 2 points of divergence (additions, deletions, or substitutions) from the controlled drug, which may consist of a single atom or a functional group or some combination thereof. Functional groups are further defined as alkyl, alkenyl, alkynyl, ring structures … amine …"
— RSA 318-B:1, XXXI-a. Same URL (MIRROR: Justia).
**RSA 318-B:1, XIII (hallucinogenic drugs, anchor)** — "'Hallucinogenic drugs' are psychodysleptic drugs … Exemplary of such drugs are mescaline, peyote, psilocybin and d-lysergic acid diethylamide."
— RSA 318-B:1, XIII. Same URL (MIRROR: Justia).7e1ece894e0c8416318-B:2, I. It shall be unlawful for any person to manufacture, possess, have under his control, sell, purchase, prescribe, administer, or transport or possess with intent to sell, dispense, or compound any controlled drug, or controlled drug analog, or any preparation containing a controlled drug, except as authorized in this chapter. 318-B:1, VI-a. (a) "Controlled drug analog" means a substance, however constituted, the chemical structure of which is derivative of, or substantially similar to that of a controlled drug and: (1) Which has been shown in laboratory studies to bind with and activate the same central nervous receptors that are responsible for the psychoactive effects of a certain controlled drug or controlled drug class; or (2) With respect to a particular person, which such person represents or intends to have similar psychoactive effects on the central nervous system as a controlled drug. (b) "Controlled drug analog" shall not include: (1) A controlled drug; (2) Any substance for which there is an approved new drug application; (3) With respect to a particular person, any substance, if an exemption is in effect for investigational use for that person under 21 U.S.C. section 355, to the extent conduct with respect to the substance is pursuant to such an exemption; or (4) Any compound, mixture, or preparation that contains any controlled drug or controlled drug analog that is not for administration to a human being or animal, and that is packaged in such a form or concentration, or with adulterants or denaturants so that, as packaged, it does not present any significant potential for abuse. 318-B:1, XXXI-a. "Substantially similar in chemical structure" means that the substance in question shares a common core structure with a controlled drug, meaning that the "backbone" of the molecule is the same, and has no more than 2 points of divergence (additions, deletions, or substitutions) from the controlled drug, which may consist of a single atom or a functional group or some combination thereof. Functional groups are further defined as alkyl, alkenyl, alkynyl, ring structures (either homocyclic or heterocyclic, with or without additional attached functional groups), organic halides, alkoxy, alcohol, ether, amine, aldehyde, ketone, carboxylic acid, ester, amide, nitrile, nitro, sulfide, thiene, thioester, or thiol.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap